Page 6 - Obstructive Sleep News Today

/PRNewswire/ -- Mosanna Therapeutics AG, a Swiss Biotech company today announced that it has secured seed financing led by Forty51 Ventures to pursue the...

Shahid Kapoor will be performing at IIFA 2022 in Abu Dhabi, but it won't be just a regular dance performance. Shahid will pay a special tribute to the late legendary singer Bappi Lahiri through his performance. 

Nyxoah (NASDAQ:NYXH – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Thursday, Zacks.com reports. The firm currently has a $16.00 price objective on the stock. Zacks Investment Research‘s target price would indicate a potential upside of 17.22% from the […]

Fans of Lata Mangeshkar and Bappi Lahiri got disappointed after the legendary singers were not included in the In Memoriam section of the 64th Annual Grammy Awards.

Zacks Investment Research lowered shares of Nyxoah (NASDAQ:NYXH – Get Rating) from a buy rating to a hold rating in a report released on Friday morning, Zacks.com reports. According to Zacks, “Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is […]

The majority of those with obstructive sleep apnea (OSA) are undiagnosed or under-diagnosed and live with symptoms that they don’t understand and can’t seem to shake. Knowing the signs is

Last March 18, World Sleep Day was observed. It was started by a group of medical professionals and its main goal is to raise awareness about the importance of good sleeping habits. These medical professionals have banded together to form the World Sleep Society. The World Sleep Society works with…

New Delhi [India], March 28 (ANI/NewsVoir): Once upon a time, a career-focused individual claimed that sleep was for the weak

(NAPSI)—Roughly 20% of U.S. adults have sleep apnea, and as many as 90% of those cases go undiagnosed. The condition occurs when people stop breathing periodically throughout the night, potentially

Zacks Investment Research upgraded shares of Nyxoah (NASDAQ:NYXH – Get Rating) from a hold rating to a buy rating in a report released on Thursday, Zacks.com reports. The brokerage currently has $21.00 target price on the stock. According to Zacks, “Nyxoah SA is a medical technology company. It focused on the development and commercialization of […]